| abstract |
The hydroxamic and carboxylic acid derivatives of formula (I), and their use in the manufacture of a pharmaceutical composition comprising these derivatives together with a pharmaceutically acceptable solution or carrier for treating or preventing a condition related to matrix metalloproteinases or caused by TNF-alpha. or enzymes involved in rejection of L-selectin, TNF receptor or IL-6 receptor. |